AAAAAA
Results:
1-7
|
Results: 7
Authors:
Isik, R
Metintas, M
Gibbs, AR
Metintas, S
Jasani, B
Oner, U
Harmanci, E
Demircan, S
Isiksoy, S
Citation: R. Isik et al., p53, p21 and metallothionein immunoreactivities in patients with malignantpleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure, RESP MED, 95(7), 2001, pp. 588-593
Authors:
Metintas, M
Metintas, S
Ucgun, I
Gibbs, AR
Harmanci, E
Alatas, F
Erginel, S
Tel, N
Pasaoglu, O
Citation: M. Metintas et al., Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristics, RESP MED, 95(10), 2001, pp. 829-835
Authors:
Ozdemir, N
Ucgun, I
Metintas, S
Kolsuz, M
Metintas, M
Citation: N. Ozdemir et al., The prevalence of asthma and allergy among university freshmen in Eskisehir, Turkey, RESP MED, 94(6), 2000, pp. 536-541
Authors:
Metintas, M
Ozdemir, N
Hillerdal, G
Ucgun, I
Metintas, S
Baykul, C
Elbek, O
Mutlu, S
Kolsuz, M
Citation: M. Metintas et al., Environmental asbestos exposure and malignant pleural mesothelioma, RESP MED, 93(5), 1999, pp. 349-355
Authors:
Metintas, M
Hillerdal, G
Metintas, S
Citation: M. Metintas et al., Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort, EUR RESP J, 13(3), 1999, pp. 523-526
Authors:
Metintas, M
Ozdemir, N
Ucgun, I
Elbek, O
Kolsuz, M
Mutlu, S
Metintas, S
Citation: M. Metintas et al., Cisplatin, mitomycin, and interferon-alpha 2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma, CHEST, 116(2), 1999, pp. 391-398
Authors:
Ucgun, I
Ozdemir, N
Metintas, M
Metintas, S
Erginel, S
Kolsuz, M
Citation: I. Ucgun et al., Prevalence of occupational asthma among automobile and furniture painters in the center of Eskisehir (Turkey): the effects of atopy and smoking habits on occupational asthma, ALLERGY, 53(11), 1998, pp. 1096-1100
Risultati:
1-7
|